Kitov Pharmaceuticals Holdings Ltd. Sponsored ADR
(NASDAQ : KTOV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.52%142.380.6%$784.32m
MRKMerck & Co., Inc.
0.38%56.220.6%$704.80m
PFEPfizer Inc.
2.00%37.190.8%$585.67m
ABBVAbbVie, Inc.
1.16%97.422.1%$456.67m
LLYEli Lilly and Company
0.07%86.561.0%$305.25m
BMYBristol-Myers Squibb Company
0.42%62.391.4%$301.27m
GSKGlaxoSmithKline plc Sponsored ADR
-0.74%34.980.2%$174.16m
NVSNovartis AG Sponsored ADR
0.47%84.870.2%$106.77m
AZNAstraZeneca PLC Sponsored ADR
-0.48%33.131.3%$91.12m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.66%52.510.1%$66.72m
SNYSanofi Sponsored ADR
0.05%43.110.2%$51.33m
SCMPSucampo Pharmaceuticals, Inc. Class A
1.49%17.0014.4%$40.06m
LCILannett Company, Inc.
-1.96%27.5538.2%$22.97m
AKTXAkari Therapeutics Plc Sponsored ADR
0.97%4.172.2%$1.56m
EPIXESSA Pharma Inc
-4.55%0.210.0%$0.02m

Company Profile

Kitov Pharmaceuticals Holdings Ltd. in the research and development of combinations of existing drugs in advanced stages of development. The company focused on the development of therapeutic candidates for the simultaneous treatment of two clinical conditions: pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for osteoarthritis. Kitov Pharmaceuticals Holdings was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.